久久做人人做人人综合,91最新人成在线观看

產(chǎn)品中心

人胎球蛋白A(FETUA)酶聯(lián)免疫吸附檢測試劑盒

ELK1207

規(guī)格：	價格：
48T	￥1680.00
96T	￥2400.00

下載說明 ①

Overview 文獻

Product name:	Human FETUA(Fetuin A) ELISA Kit
Reactivity:	Human
Alternative Names:	HSGa; A2HS; AHS; FETUA; HSG-A2; Fetuin-A; Alpha 2-HS Glycoprotein; Fetuin A; Alpha-2-Z-Globulin;? Ba-alpha-2-Glycoprotein; Alpha-2-Heremans Schmid Glycoprotein; aHSG
Assay Type:	Sandwich
Sensitivity:	0.38 ng/mL
Standard:	50 ng/mL
Detection Range:	0.79-50 ng/mL
Sample Type:	serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Assay Length:	3.5h
Research Area:	Infection immunity;
Uniprot ID:	P02765
Test principle:	The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human FETUA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human FETUA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human FETUA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human FETUA in the samples is then determined by comparing the OD of the samples to the standard curve.

ASIAN CARDIOVASCULAR & THORACIC ANNALS

Fetuin-A as a plausible biomarker for cardiac valve calcification in rheumatic heart disease patients from North India

日期：2025-01-17 IF：
ASIAN CARDIOVASCULAR & THORACIC ANNALS

Fetuin-A as a plausible biomarker for cardiac valve calcification in rheumatic heart disease patients from North India

日期：2025-01-17 IF：
ASIAN CARDIOVASCULAR & THORACIC ANNALS

Fetuin-A as a plausible biomarker for cardiac valve calcification in rheumatic heart disease patients from North India

日期：2025-01-17 IF：
ASIAN CARDIOVASCULAR & THORACIC ANNALS

Fetuin-A as a plausible biomarker for cardiac valve calcification in rheumatic heart disease patients from North India

日期：2025-01-17 IF：

標(biāo)準曲線

Concentration (ng/mL)	OD	Corrected OD
50.00	2.079	1.996
25.00	1.556	1.473
12.50	1.128	1.045
6.25	0.801	0.718
3.13	0.614	0.531
1.57	0.305	0.222
0.79	0.235	0.152
0.00	0.083	0.000

精密度

Intra-assay Precision (Precision within an assay)：CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays)：CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

回收率

Matrices listed below were spiked with certain level of recombinant FETUA and the recovery rates were calculated by comparing the measured value to the expected amount of FETUA in samples.

Matrix	Recovery range	Average
serum(n=5)	85-97%	91%
EDTA plasma(n=5)	82-97%	89%
Heparin plasma(n=5)	87-95%	91%

線性

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of FETUA and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.